- Home
- TRMD vs APGE Comparison
TRMD vs APGE Comparison
Compare TRMD & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRMD
- APGE
- Stock Information
- Founded
- TRMD 1889
- APGE 2022
- Country
- TRMD United Kingdom
- APGE United States
- Employees
- TRMD N/A
- APGE N/A
- Industry
- TRMD Marine Transportation
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TRMD Consumer Discretionary
- APGE Health Care
- Exchange
- TRMD Nasdaq
- APGE Nasdaq
- Market Cap
- TRMD 2.1B
- APGE 2.0B
- IPO Year
- TRMD N/A
- APGE 2023
- Fundamental
- Price
- TRMD $23.22
- APGE $36.86
- Analyst Decision
- TRMD Buy
- APGE Strong Buy
- Analyst Count
- TRMD 1
- APGE 5
- Target Price
- TRMD $23.00
- APGE $95.40
- AVG Volume (30 Days)
- TRMD 811.4K
- APGE 471.5K
- Earning Date
- TRMD 11-06-2025
- APGE 11-11-2025
- Dividend Yield
- TRMD 11.22%
- APGE N/A
- EPS Growth
- TRMD N/A
- APGE N/A
- EPS
- TRMD 3.31
- APGE N/A
- Revenue
- TRMD $1,321,800,000.00
- APGE N/A
- Revenue This Year
- TRMD N/A
- APGE N/A
- Revenue Next Year
- TRMD N/A
- APGE N/A
- P/E Ratio
- TRMD $7.00
- APGE N/A
- Revenue Growth
- TRMD N/A
- APGE N/A
- 52 Week Low
- TRMD $13.60
- APGE $26.20
- 52 Week High
- TRMD $36.78
- APGE $63.50
- Technical
- Relative Strength Index (RSI)
- TRMD 66.36
- APGE 46.14
- Support Level
- TRMD $21.81
- APGE $36.81
- Resistance Level
- TRMD $23.65
- APGE $38.84
- Average True Range (ATR)
- TRMD 0.55
- APGE 1.56
- MACD
- TRMD -0.01
- APGE 0.01
- Stochastic Oscillator
- TRMD 87.09
- APGE 37.34
About TRMD TORM plc
TORM PLC operates as a shipping company. The company owns and operates product tankers. It is engaged in the transportation of refined oil products The company transports clean petroleum products including gasoline, jet fuel, naphtha, and diesel oil, as well as other clean products. Its segments include the Tanker segment, and Marine Engineering segment. The company derives maximum revenue from Tanker segment.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.